This Medudy course is a video tutorial for physicians on the topic of "Risk score for the prognosis of acute renal failure after cisplatin administration". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
Cisplatin is a powerful chemotherapeutic agent that is often used to treat various types of cancer. However, acute kidney injury is a common and serious side effect of cisplatin. Today's study was therefore specifically designed to develop and externally validate a predictive model for severe acute kidney injury associated with cisplatin.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this course you will know
- the clinical background and relevance of the research question under investigation
- the study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
